Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
AstraZeneca Launches Sixth Global R&D Center in Beijing to Accelerate China Investments
October 27, 2025
Company
Drug
Chiesi Group Launches First EB Wound Treatment in China
October 27, 2025
Company
Deals
Chugai to Acquire Renalys Pharma for JPY 31 Billion to Expand IgA Nephropathy Treatment Portfolio
October 27, 2025
Company
Drug
Innovent’s Mazdutide Meets Phase III Endpoint in Type 2 Diabetes and Obesity Trial
October 27, 2025
Company
Sunshine Guojian Reports Strong Q3 Growth and Advances Key R&D Programs
October 27, 2025
Company
Astellas Establishes First China Innovation R&D Center in Beijing BioPark
October 27, 2025
Company
Deals
Novartis Transfers Lucentis and Beovu Rights to CMS Vision in China Deal
October 27, 2025
Company
Deals
GSK Secures Global Rights to Syndivia’s ADC for Metastatic Prostate Cancer
October 27, 2025
Company
Drug
Zhifei’s CA111 Injection Approved for Clinical Trials Targeting Weight Loss and Hypoglycemia
October 27, 2025
Company
Drug
LEO Pharma Submits NDA for Anzupgo in China for Chronic Hand Eczema
October 27, 2025
Company
Deals
Eli Lilly Partners with Cipla to Distribute New Tirzepatide Brand “Yurpeak” in India
October 25, 2025
Company
Drug
Alphamab Announces First Patient Dosed with JSKN022, a PD‑L1/αvβ6 Bispecific ADC
October 24, 2025
1
2
…
42
43
44
45
46
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
